Differding Consulting s.p.r.l. was established in 2010 to offer strategic advice on drug discovery activities to pharmaceutical companies, biotech companies and research institutes.
We focus on two areas:
- Outsourcing and partnering drug discovery activities
- Drug discovery consultancy
Differding Consulting s.p.r.l. is based in Louvain-la-Neuve (Belgium), South of Brussels, and is building on an expanding global network with contract research organizations, in particular in Asia, and a special focus on India.
26.02.14 | AUNP-12 - A NOVEL PEPTIDE THERAPEUTIC TARGETING PD-1 IMMUNE CHECKPOINT PATHWAY FOR CANCER IMMUNOTHERAPY – STRUCTURE ACTIVITY RELATIONSHIPS & PEPTIDE / PEPTIDOMIMETIC ANALOGS
Aurigene Discovery Technologies, the Bangalore-based biotech company, and Pierre Fabre, the second largest independent French pharmaceutical company, announced on February 11, 2014, a collaborative license, development and commercialization agreement giving Pierre Fabre worldwide rights (excluding India) to a new immune checkpoint modulator, AUNP-12, for the treatment of cancer.
29.10.13 | DRUG DISCOVERY ALLIANCES IN INDIA - INDICATIONS, TARGETS AND NEW CHEMICAL ENTITIES
Global pharmaceutical and biotechnology companies have been building increasingly on the skills and services offered by Indian biotech companies. With the exception of generic press releases, however, very little has been published on the process and progress of drug discovery itself. In this review, we have analyzed recent patents, patent applications, and peer-reviewed publications of major research alliances, with the aim of highlighting their scientific output...